Knocking Down CDKN2A Enhances the Therapeutic Effects of Metformin and Resveratrol on Diabetic Retinopathy

  • Appl Biochem Biotechnol. 2026 Jun;198(6):4353-4375. doi: 10.1007/s12010-026-05664-3.
Jinghua Li  #  1 ,  Junyi Liu  #  1 ,  Jiang Li  2 ,  Yongying Tang  1 ,  Zailin Xiao  3 ,  Yan Xu  1 ,  Xueying Zhao  4
Affiliations
  • 1. Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650000, China.
  • 2. Ophthalmology Department, Kunming Children's Hospital, Kunming, 650100, China.
  • 3. Ophthalmology Department, Qujing Aier Eye Hospital, 655000, Qujing, China.
  • 4. Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650000, China. [email protected].
  • # Contributed equally.
PMID: 41843007 DOI: 10.1007/s12010-026-05664-3
Keywords
CDKN2A; Diabetic retinopathy; METTL3; Mitochondrial function; m6A Methylation.
Products